glp-1 constipation lawsuit in west virginia semaglutide class action Semaglutide for the treatment of cognitive dysfunction in major depressive disorder: A randomized clinical trial Patients Are Suing Over Alleged
Description
Diabetologia 62, 10241035
Its the first step toward a healthier you
As cardiovascular risk climbs after menopause, we know that when we lose our estrogen, our risk for cardiovascular events goes up, up, up
The bottom line Nausea is a common side effect when taking a GLP-1 because of the way the medication slows down digestion
Plaintiffs allege that GLP-1 agonists drug manufacturers were aware of the link between these medications and gastroparesis based on clinical trial data yet chose not to prominently disclose or warn about this risk
